Business Rheum: What to Expect from New MVP Measures

Ultimately, Dr. Huston believes the ACR’s front-end work on developing the rheumatology-specific MVP will help rheumatologists succeed with the new model.

Dr. Harvey encouraged rheumatologists to share feedback on the MVP and, once it is implemented, how it works for practices. These comments can help the ACR advocate with the CMS for improvements.

“New payment models are often big sea changes,” he said. “I’m relieved that this is a more incremental change. The [ability to] step in and test drive is really important for us.”

Vanessa Caceres is a medical writer in Bradenton, Fla.

In November, the CMS finalized 12 MIPS Value Pathways (MVP) in the Quality Payment Program, including a rheumatology MVP. In 2023, clinicians can opt to report via traditional MIPS, the rheumatology MVP or both.

The MIPS Value Pathways will streamline federal reporting to better incentivize quality improvement. Start preparing for MVP with this session at ACR Convergence 2021.

See key changes for the Merit-Based Incentive Payment System for the 2024 performance year as outlined in the proposed rule.

The field of rheumatology is leading the way in the Centers for Medicare and Medicaid Services’ new MIPS Value Pathways with rheumatology-specific quality measures and improvement activities.

Evolution of Medicare’s Merit-Based Incentive Payment System: MIPS Value Pathways

Business of Rheum Session to Outline What to Expect with MIPS Value Pathways

2024 Proposed Rule for the Quality Payment Program Released

Looking Forward to the Rheumatology MIPS Value Pathway

Related Articles